Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11,989 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic and Clinical Value of Cluster Analysis in Idiopathic Pleuroparenchymal Fibroelastosis Phenotypes.
Nakamura Y, Mori K, Enomoto Y, Kono M, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Nakamura H, Hayakawa H, Suda T. Nakamura Y, et al. Among authors: yamada t. J Clin Med. 2021 Apr 4;10(7):1498. doi: 10.3390/jcm10071498. J Clin Med. 2021. PMID: 33916508 Free PMC article.
Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.
Enomoto Y, Nakamura Y, Satake Y, Sumikawa H, Johkoh T, Colby TV, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Inui N, Iwashita T, Kuroishi S, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T. Enomoto Y, et al. Among authors: yamada t. Respir Med. 2017 Dec;133:1-5. doi: 10.1016/j.rmed.2017.11.003. Epub 2017 Nov 6. Respir Med. 2017. PMID: 29173442 Free article.
Pneumothorax in Patients with Idiopathic Pleuroparenchymal Fibroelastosis: Incidence, Clinical Features, and Risk Factors.
Kono M, Nakamura Y, Enomoto Y, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Miki Y, Hashimoto D, Fujisawa T, Enomoto N, Inui N, Kaida Y, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Nakamura H, Suda T. Kono M, et al. Among authors: yamada t. Respiration. 2021;100(1):19-26. doi: 10.1159/000511965. Epub 2021 Jan 5. Respiration. 2021. PMID: 33401281
Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma.
Mori K, Fujisawa T, Inui N, Hashimoto D, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Toyoshima M, Imokawa S, Yamada T, Shirai T, Masuda M, Hayakawa H, Chida K, Suda T. Mori K, et al. Among authors: yamada t. Respir Med. 2016 Oct;119:1-6. doi: 10.1016/j.rmed.2016.08.007. Epub 2016 Aug 15. Respir Med. 2016. PMID: 27692128 Free article. Clinical Trial.
Low-dose Fluticasone Propionate in Combination With Salmeterol in Patients With Chronic Obstructive Pulmonary Disease.
Yasui H, Inui N, Fujisawa T, Karayama M, Enomoto N, Nakamura Y, Kuroishi S, Ohba H, Yokomura K, Sato J, Sato M, Koshimizu N, Toyoshima M, Yamada T, Masuda M, Shirai T, Suda T. Yasui H, et al. Among authors: yamada t. Clin Med Insights Circ Respir Pulm Med. 2018 May 7;12:1179548418771702. doi: 10.1177/1179548418771702. eCollection 2018. Clin Med Insights Circ Respir Pulm Med. 2018. PMID: 29881320 Free PMC article.
Efficacy of short-term prednisolone treatment in patients with chronic eosinophilic pneumonia.
Oyama Y, Fujisawa T, Hashimoto D, Enomoto N, Nakamura Y, Inui N, Kuroishi S, Yokomura K, Toyoshima M, Yamada T, Shirai T, Masuda M, Yasuda K, Hayakawa H, Chida K, Suda T. Oyama Y, et al. Among authors: yamada t. Eur Respir J. 2015 Jun;45(6):1624-31. doi: 10.1183/09031936.00199614. Epub 2015 Jan 22. Eur Respir J. 2015. PMID: 25614171 Free article. Clinical Trial.
Evaluation of palonosetron and dexamethasone with or without aprepitant to prevent carboplatin-induced nausea and vomiting in patients with advanced non-small-cell lung cancer.
Kusagaya H, Inui N, Karayama M, Fujisawa T, Enomoto N, Kuroishi S, Nakamura Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yamada T, Shirai T, Hayakawa H, Suda T. Kusagaya H, et al. Among authors: yamada t. Lung Cancer. 2015 Dec;90(3):410-6. doi: 10.1016/j.lungcan.2015.11.009. Epub 2015 Nov 7. Lung Cancer. 2015. PMID: 26791800 Clinical Trial.
Maintenance therapy with pemetrexed and bevacizumab versus pemetrexed monotherapy after induction therapy with carboplatin, pemetrexed, and bevacizumab in patients with advanced non-squamous non small cell lung cancer.
Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Yokomura K, Koshimizu N, Sato M, Toyoshima M, Shirai T, Masuda M, Yamada T, Imokawa S, Suda T. Karayama M, et al. Among authors: yamada t. Eur J Cancer. 2016 May;58:30-7. doi: 10.1016/j.ejca.2016.01.013. Epub 2016 Feb 27. Eur J Cancer. 2016. PMID: 26922170 Clinical Trial.
Sequential addition of aprepitant in patients receiving carboplatin-based chemotherapy.
Suzuki S, Karayama M, Inui N, Kuroishi S, Fujisawa T, Enomoto N, Nakamura Y, Yokomura K, Toyoshima M, Imokawa S, Asada K, Masuda M, Yamada T, Watanabe H, Hayakawa H, Suda T. Suzuki S, et al. Among authors: yamada t. Med Oncol. 2016 Jul;33(7):65. doi: 10.1007/s12032-016-0780-6. Epub 2016 May 27. Med Oncol. 2016. PMID: 27235141 Clinical Trial.
Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancer.
Suzuki S, Karayama M, Inui N, Fujisawa T, Enomoto N, Nakamura Y, Kuroishi S, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Asada K, Masuda M, Yamada T, Watanabe H, Suda T. Suzuki S, et al. Among authors: yamada t. Invest New Drugs. 2016 Aug;34(4):490-6. doi: 10.1007/s10637-016-0365-4. Epub 2016 Jun 9. Invest New Drugs. 2016. PMID: 27279143 Clinical Trial.
11,989 results
You have reached the last available page of results. Please see the User Guide for more information.